Arca
Skip to content
Tools
Tools

Brainsway Deep Transcranial Magnetic Stimulation (DTMS) System

Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder. De Novo DEN170078, from Brainways , Ltd. (Har Hotzvim, IL). Product code QCI, class 2.

As of Nov 22, 2026, DEN170078 is an FDA De Novo held by Brainways , Ltd., granted on Aug 17, 2018 after 322 days, with no recalls tied to it in FDA's recall database.

  • Review time: 322 days
  • Recalls: 0
  • Cited as a predicate by: 4 devices

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The Brainsway Deep Transcranial Magnetic Stimulation System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder. FDA concludes that this device should be classified into Class II.

Pivotal study

The main clinical evidence FDA relied on, as its decision summary describes it
Design
Randomized, double-blind, multi-site, sham-controlled study (1:1 allocation)
Enrolled
100
Where
11 sites, US, Israel, Canada
Primary endpoint
Change from baseline in YBOCS score to 6 weeks, DTMS vs. sham
Result
Met on mITT: DTMS -6.0 vs. Sham -3.3 points, difference 2.8 (p=0.0127); ITT difference 1.9 not significant (p=0.0988)

Cited as a predicate

4 later 510(k) summaries name this device as a predicate

Other QCI clearances

The newest 510(k)s for the same product code; their median review was 289 days; see every QCI device

Record

Type
Direct
Received
Sep 29, 2017
Review panel
Neurology
Regulation
21 CFR 882.5802

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.